quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 14, 2026

Public Storage outlines PS4.0 transition and projects $16.35–$17 core FFO for 2026, with strategic leadership realignment

View original at seekingalpha.com
Public Storage outlines PS4.0 transition and projects $16.35–$17 core FFO for 2026, with strategic leadership realignment Earnings Call Insights: Public Storage (PSA) Q4 2025 MANAGEMENT VIEW * CEO Joseph Russell announced a generational leadership transition with Tom Boyle promoted to CEO and Trustee, stating “Tom and…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Move-in rents for January down 7% with sequential improvement. Continued evolution as we think about attracting the right customers at the top of funnel, being able to understand what we think their length of stays are going to be and their price elasticities.

    80% confidence
  • We believe occupancy for the year will remain roughly stable. Move-in rents will remain negative in the mid-single digits for the year, but will improve throughout the year, and our ECRI contribution will continue to help support total revenue.

    80% confidence
  • Declines in move-in rents were offset by strong existing customer performance, resulting in in-place rents up 20 basis points and occupancy down 20 basis points

    80% confidence
  • From 2023 to 2025, Public Storage has led the sector in same-store revenue growth, NOI growth and NOI margins. Core FFO per share growth leads the sector. Total shareholder returns of 18.6% outperformed peers over that time frame.

    80% confidence
  • Joe Fisher has tenure at UDR as President, CFO and CIO, along with stature in the REIT industry

    80% confidence
  • We're certainly aware of some of the recent pronouncements out of New York, for instance, and other states around pricing transparency and making sure we're in compliance

    80% confidence
  • Core FFO in the quarter was $4.26 per share, resulting in full year core FFO of $16.97 per share at the high end of guidance range. Same-store revenue and NOI growth in the quarter were minus 0.2% and minus 1.5%, respectively.

    80% confidence
  • Negative same-store NOI growth and refinancing activity is being offset by positive contributions from non-same-store pool and tenant insurance program

    80% confidence
  • Tom and I have been partners for nearly a decade since we both joined Public Storage in 2016. Tom has proven to be an exceptional leader in both his CFO and CIO roles with outstanding accomplishments across capital allocation, operations and financial strategy.

    80% confidence
  • Year-over-year revenue is a backward-looking indicator. Occupancy for the year, we expect will be relatively static. New move-ins, we do forecast that while down mid-single digits for the year, we're going to start low and continue to lift throughout the year.

    80% confidence
  • Los Angeles state of emergency resulting in a drag on same-store revenue of approximately 80 basis points

    80% confidence
  • We had a good number of single and double type opportunities and we continue to try to capture as well as small and medium-sized portfolios. We're investing in the team. Our data science team has done tremendous work streamlining our processes and looking to take advantage of the industry's largest data set.

    80% confidence
  • This is a generational transition and a strategic vision designed to drive accelerated performance. Our objective is simple: build the best team to attack the opportunity ahead, and we have.

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com